DIAPH3 and cancer: Using the pan-cancer analysis in the Tumor Immune Estimation Resource (TIMER) database (Figure 7A) and TCGA database (Figure 7B), we observed that DIAPH3 was highly expressed in cervical cancer and multiple tumors.